Agitation | ED50 of Dexmedetomidine to Prevent Emergence Agitation in Children

Agitation research study

What is the primary objective of this study?

There are several recommended doses of dexmedetomidine for prevention of emergence agitation in children. In this study, the investigators examine ED50 in prevention of emergence agitation after tonsillectomy or adenoidectomy in children.

Who is eligible to participate?

Inclusion Criteria: - tonsillectomy or adenoidectomy Exclusion Criteria: - recent URI

Which medical condition, disease, disorder, syndrome, illness, or injury is researched?


Study Interventions

Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.

Drug:Dexmedetomidinedexmedetomidine, 0.1ug/kg up or down

Study Arms

Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.

dexmedetomidine, children

Study Status

Unknown status

Start Date: June 2011

Completed Date: February 2012

Phase: Phase 4

Type: Interventional


Primary Outcome: agitation

Secondary Outcome: pain

Study sponsors, principal investigator, and references

Principal Investigator: Hee-Soo Kim, M.D, PhD

Lead Sponsor: Seoul National University Hospital


More information:

Discuss Agitation